Latest / The DISRUPTED SCIENCE Podcast
March 4, 2026 — Why Should We Trust You?
John Wiley & Sons is at it again with its “date anyone with a cute AI” approach, announcing yesterday a deal with OpenEvidence (OE). This is nothing new for Wiley, a company that seems more infatuated with tech than it is with science and scholarship, a massive departure from its roots.
OE is certainly happy to make the deal, but not for the quality of the content. Rather, it keeps their targeted ad business growing. Platforming medical and health content is simply laying the groundwork for making a Facebook of medical information — a platform designed to sell user-targeted ads with the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.